Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Nifty June futures trade at premium
HDFC Bank (India), Reliance Industries and Infosys were the top traded contract.
Nifty June futures trade at premium
Infosys, TCS and HDFC Bank were top traded contracts
Nifty June futures trade at premium
Tata Motors PV, HDFC Bank and Infy were top traded contracts
Sensex rises over 250 points, Nifty above 24,000 as Dalal Street extends gains for 4th session. What lies ahead?
Indian stock markets are trading higher today. The Sensex and Nifty are extending their gains for the fourth consecutive session. This rally is fueled by a recent Iran-US deal framework and a significant drop in oil prices. Key companies like IndiGo and Mahindra & Mahindra are leading the gains.
Nifty June futures trade at a premium
HDFC Bank, Reliance Inds and L&T were top traded contracts
Nifty June futures trade at a premium
HDFC Bank, ICICI Bank and Reliance Industries were the top traded contracts.
Nifty June futures trade at a premium
HDFC Bank, Reliance Industries and ICICI Bank were the top traded contracts.

Nifty 500 Q4 Review: HDFC Bank, Indian Oil, Tata Motors Among Top Winners, Losers; Key Sector Trend — Read Motilal Oswal's Report
Of the 23 key sectors, 14 posted double-digit profit growth in Q4 FY26.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
Nifty June futures trade at premium
HDFC Bank (India), State Bank of India and Reliance Industries were top traded contracts.